Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 1
1962 1
1963 1
1965 1
1966 2
1967 2
1968 4
1969 1
1970 1
1972 1
1973 1
1974 5
1975 6
1976 5
1977 2
1978 3
1979 1
1981 5
1982 2
1983 3
1984 10
1985 15
1986 19
1987 23
1988 13
1989 24
1990 19
1991 30
1992 14
1993 15
1994 10
1995 25
1996 14
1997 25
1998 19
1999 14
2000 20
2001 19
2002 29
2003 40
2004 45
2005 42
2006 60
2007 74
2008 78
2009 125
2010 115
2011 131
2012 119
2013 122
2014 156
2015 138
2016 171
2017 150
2018 121
2019 147
2020 213
2021 210
2022 200
2023 197
2024 230
2025 206

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,167 results

Results by year

Filters applied: . Clear all
Page 1
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial.
Wu YL, Cheng Y, Zhou J, Lu S, Zhang Y, Zhao J, Kim DW, Soo RA, Kim SW, Pan H, Chen YM, Chian CF, Liu X, Tan DSW, Bruns R, Straub J, Johne A, Scheele J, Park K, Yang JC; INSIGHT Investigators. Wu YL, et al. Among authors: chen ym. Lancet Respir Med. 2020 Nov;8(11):1132-1143. doi: 10.1016/S2213-2600(20)30154-5. Epub 2020 May 29. Lancet Respir Med. 2020. PMID: 32479794 Clinical Trial.
Long-term risk of coronary events after AKI.
Wu VC, Wu CH, Huang TM, Wang CY, Lai CF, Shiao CC, Chang CH, Lin SL, Chen YY, Chen YM, Chu TS, Chiang WC, Wu KD, Tsai PR, Chen L, Ko WJ; NSARF Group. Wu VC, et al. Among authors: chen ym. J Am Soc Nephrol. 2014 Mar;25(3):595-605. doi: 10.1681/ASN.2013060610. Epub 2014 Feb 6. J Am Soc Nephrol. 2014. PMID: 24503241 Free PMC article.
Uremic frost.
Kuo CC, Hung JB, Tsai CW, Chen YM. Kuo CC, et al. Among authors: chen ym. CMAJ. 2010 Nov 23;182(17):E800. doi: 10.1503/cmaj.091779. Epub 2010 Aug 9. CMAJ. 2010. PMID: 20696798 Free PMC article. No abstract available.
Primary aldosteronism: diagnostic accuracy of the losartan and captopril tests.
Wu VC, Chang HW, Liu KL, Lin YH, Chueh SC, Lin WC, Ho YL, Huang JW, Chiang CK, Yang SY, Chen YM, Wang SM, Huang KH, Hsieh BS, Wu KD; TAIPAI Study Group. Wu VC, et al. Among authors: chen ym. Am J Hypertens. 2009 Aug;22(8):821-7. doi: 10.1038/ajh.2009.89. Epub 2009 May 14. Am J Hypertens. 2009. PMID: 19444221
Residual urine output and postoperative mortality in maintenance hemodialysis patients.
Lin YF, Wu VC, Ko WJ, Chen YS, Chen YM, Li WY, Chou NK, Chao A, Huang TM, Chang FC, Chen SI, Shiao CC, Wang WJ, Tsai HB, Tsai PR, Hu FC, Wu KD; National Taiwan University Surgical Intensive Care Unit-Associated Renal Failure Study Group. Lin YF, et al. Among authors: chen ym. Am J Crit Care. 2009 Sep;18(5):446-55. doi: 10.4037/ajcc2009577. Am J Crit Care. 2009. PMID: 19723865
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial.
Schuler M, Yang JC, Park K, Kim JH, Bennouna J, Chen YM, Chouaid C, De Marinis F, Feng JF, Grossi F, Kim DW, Liu X, Lu S, Strausz J, Vinnyk Y, Wiewrodt R, Zhou C, Wang B, Chand VK, Planchard D; LUX-Lung 5 Investigators. Schuler M, et al. Among authors: chen ym. Ann Oncol. 2016 Mar;27(3):417-23. doi: 10.1093/annonc/mdv597. Epub 2015 Dec 8. Ann Oncol. 2016. PMID: 26646759 Free PMC article. Clinical Trial.
Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors.
Petoumenos K, Hui E, Kumarasamy N, Kerr SJ, Choi JY, Chen YM, Merati T, Zhang F, Lim PL, Sungkanuparph S, Pujari S, Ponnampalavanar S, Ditangco R, Lee CK, Grulich A, Law MG; TREAT Asia HIV Observational Database. Petoumenos K, et al. Among authors: chen ym. J Int AIDS Soc. 2010 Dec 10;13:51. doi: 10.1186/1758-2652-13-51. J Int AIDS Soc. 2010. PMID: 21143940 Free PMC article.
Impact of timing of renal replacement therapy initiation on outcome of septic acute kidney injury.
Chou YH, Huang TM, Wu VC, Wang CY, Shiao CC, Lai CF, Tsai HB, Chao CT, Young GH, Wang WJ, Kao TW, Lin SL, Han YY, Chou A, Lin TH, Yang YW, Chen YM, Tsai PR, Lin YF, Huang JW, Chiang WC, Chou NK, Ko WJ, Wu KD, Tsai TJ; NSARF Study Group. Chou YH, et al. Among authors: chen ym. Crit Care. 2011;15(3):R134. doi: 10.1186/cc10252. Epub 2011 Jun 6. Crit Care. 2011. PMID: 21645350 Free PMC article.
3,167 results